The expression pattern of nitric oxide-sensitive guanylyl cyclase in the rat heart changes during postnatal development

Journal of Histochemistry and Cytochemistry

Volumn 50, Issue 10, 2002, Pages 1325-1331

  Behrends, Sönke ^a   Mietens, Andrea ^a   Kempfert, Jörg ^a   Koglin, Markus ^a   Scholz, Hasso ^a   Middendorff, Ralf ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cardiomyocyte; Endothelium; Nitric oxide; Smooth muscle cell; Soluble guanylyl cyclase

Indexed keywords

GLYCERYL TRINITRATE; GUANYLATE CYCLASE; NITRIC OXIDE; RECEPTOR PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; HEART DEVELOPMENT; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; MALE; NONHUMAN; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALIA;

EID: 0036796880     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540205001005     Document Type: Article

References (33)

1. Andreopoulos S, Papapetropoulos A (2000) Molecular aspects of soluble guanylyl cyclase regulation. Gen Pharmacol 34:147-157
2. Anversa P, Loud AV, Giacomelli F, Wiener J (1978) Absolute morphometric study of myocardial hypertrophy in experimental hypertension. II. Ultrastructure of myocytes and interstitium. Lab Invest 38:597-609
3. Anversa P, Olivetti G, Melissari M, Loud AV (1979) Morphometric study of myocardial hypertrophy induced by abdominal aortic stenosis. Lab Invest 40:341-349
4. Bache RJ, Ball RM, Cobb FR, Rembert JC, Greenfield JC Jr (1975) Effects of nitroglycerin on transmural myocardial blood flow in the unanesthetized dog. J Clin Invest 55:1219-1228
5. Balligand JL (1999) Regulation of cardiac beta-adrenergic response by nitric oxide. Cardiovasc Res 43:607-620
6. Behrends S, Kempfert J, Mietens A, Koglin M, Scholz H, Middendorff R (2001) Developmental changes of nitric oxide sensitive guanylyl cyclase expression in pulmonary arteries. Biochem Biophys Res Commun 283:883-887
7. Bloch KD, Filippov G, Sanchez LS, Nakane M, de la Monte SM (1997) Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period. Am J Physiol 272:L400-406
8. Chen L, Daum G, Fischer JW, Hawkins S, Bochaton-Piallat ML, Gabbiani G, Clowes AW (2000) Loss of expression of the beta subunit of soluble guanylyl cyclase prevents nitric oxide-mediated inhibition of DNA synthesis in smooth muscle cells of old rats. Circ Res 86:520-525
9. Cohn PF, Maddox D, Holman BL, Markis JE, Adams DF, See JR, Idoine J (1977) Effect of sublingually administered nitroglycerin on regional myocardial blood flow in patients with coronary artery disease. Am J Cardiol 39:672-678
10. Denninger JW, Marletta MA (1999) Guanylate cyclase and the NO/cGMP signaling pathway. Biochim Biophys Acta 1411:334-350
11. Friebe A, Koesling D (1998) Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol Pharmacol 53:123-127
12. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376
13. Gandhi A, Yan L, Scholz PM, Huang MW, Weiss HR (1999) Cyclic GMP reduces ventricular myocyte stunning after simulated ischemia-reperfusion. Nitric Oxide 3:473-480
14. Goldstein RE, Stinson EB, Scherer JL, Seningen RP, Grehl TM, Epstein SE (1974) Intraoperative coronary collateral function in patients with coronary occlusive disease: nitroglycerin responsiveness and angiographic correlations. Circulation 49:298-308
15. He P, Zeng M, Curry FE (1998) cGMP modulates basal and activated microvessel permeability independently of [Ca2+]i. Am J Physiol 274:H1865-1874
16. Isenberg G, Klockner U (1982) Calcium tolerant ventricular myocytes prepared by preincubation in a "KB medium." Pflugers Arch 395:6-18
17. Klassen CL, Traverse JH, Bache RJ (1999) Nitroglycerin dilates coronary collateral vessels during exercise after blockade of endogenous NO production. Am J Physiol 277:H918-923
18. Koglin M, Vehse K, Budaeus L, Scholz H, Behrends S (2001) Nitric oxide activates the β2 subunit of soluble guanylyl cyclase in the absence of a second subunit. J Biol Chem 276:30737-30743
19. Mayhan WG (1999) VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am J Physiol 276:C1148-1153
20. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M (1996) Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 270:H411-415
21. Müller-Strahl G, Kottenberg K, Zimmer HG, Noack E, Kojda G (2000) Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart. J Physiol 522:311-320
22. Olivetti G, Anversa P, Loud AV (1980) Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. II. Tissue composition, capillary growth, and sarcoplasmic alterations. Circ Res 46:503-512
23. Rakhit RD, Edwards RJ, Mockridge JW, Baydoun AR, Wyatt AW, Mann GE, Marber MS (2000) Nitric oxide-induced cardioprotection in cultured rat ventricular myocytes. Am J Physiol 278:H1211-1217
24. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR (2000) Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 97:5930-5935
25. Russwurm M, Behrends S, Harteneck C, Koesling D (1998) Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. Biochem J 335:125-130
26. Schultz G, Böhme E (1984) Guanylate cyclase. GTP pyrophosphatelyase (cyclizing), E.C.4.6.1.2. In Bergmeyer HU, Bergmeyer J, Grassl M, (eds.) Methods of Enzymatic Analysis. 3rd ed. Vol 4. Weinheim, Verlag Chemie, 379-389
27. Stasch JP, Becker EM, Alonso-Alija C, Apeler H, Dembowsky K, Feurer A, Gerzer R (2001) NO-independent regulatory site on soluble guanylate cyclase. Nature 410:212-215
28. Tomanek RJ, Haung L, Suvarna PR, O'Brien LC, Ratajska A, Sandra A (1996) Coronary vascularization during development in the rat and its relationship to basic fibroblast growth factor. Cardiovasc Res 31:E116-126
29. Vila-Petroff MG, Younes A, Egan J, Lakatta EG, Sollott SJ (1999) Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 84:1020-1031
30. Wegener JW, Gath I, Förstermann U, Nawrath H (1997) Activation of soluble guanylyl cyclase by YC-1 in aortic muscle but not in ventricular myocardium from rat. Br J Pharmacol 122:1523-1529
31. Williams JF Jr, Glick G, Braunwald E (1965) Studies on cardiac dimensions in intact unanesthetized man. V. Effects of nitroglycerin. Circulation 32:767-771
32. Wu CC, Ko FN, Kuo SC, Lee FY, Teng CM (1995) YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br J Pharmacol 116:1973-1978
33. Wu HM, Huang Q, Yuan Y, Granger HJ (1996) VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol 271:H2735-2739